Objective: Improving the well-being of mothers, infants, and children is an important public health goal across the world. Their well-being determines the health of the next generation and can help predict future public health challenges for families, communities, and the health care system. The Global Research in Pediatric project funded by the European Commission, the International Society for Pharmaco-epidemiology and the FDA demonstrated that there is an urgent need to build research capacity to better exploit the evidence that is being compiled in real life. Especially in these vulnerable groups, which are often excluded from clinical trials and where most drugs are used off label, data generated in routine health care should be utilized. Data should be made actionable and provide evidence that can support mothers, parents and health care providers and public health officials to make better informed decisions. However, there are several methodological challenges that are related to - Linkage of mothers and their children in health care databases - Estimation of gestational age and pregnancy in health care databases - Long-term follow-up of children - Pregnancy and neonatal outcome phenotyping in health care databases - Exposure & confounder patterns in children: dose and duration of drugs and co-morbidities
The OHDSI maternal child health group aims to specifically address: - Methods & validation for mother-child linkage in health care databases - Designs, methods and implementation of multisite drug utilization studies and vaccine coverage in mothers and children - Estimation of recurrent/chronic disease incidence and prevalence in children and mothers using health care databases - Methods and designs for maternal drug/vaccine exposure and pediatric drug/vaccine exposure outcome studies (safety & effectiveness)
After the kick off meeting the chairs have created a list of specific activities to start off with.
Proposed tasks for community contribution:
Generate and characterize pregnancy episodes in databases across the OHDSI network using available code
Project Leads: Miriam Sturkenboom (Utrecht University Medical Center), Jamie Weaver (J&J)
Next meeting: 30 March 2018 at 9am EST/2pm CET
Repository: Minutes
December 2017: https://www.dropbox.com/s/9nnpwnr43bqfu7k/MCH%20Working%20Group%20meeting_minutes20171205.docx?dl=0
Schedule: to be defined
Next Meeting: (Date and Time) March 30 9am EST/2pm CET
Agenda: 1) Introductions 2) Discussion on proposed activities 3) Presentation Jamie Weaver: Estimation of gestational age and pregnancy in health care databases & mother child linkage. background http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0192033 4) Discussion on contributions to the community on topics discussed by Jamie 5) Presentation Miriam Sturkenboom on GAIA maternal and neonatal outcome definitions/codes and discussion on ability to identify outcomes/phenotyping in community
OHDSI WG Maternal & Child Health Fri, Mar 30, 2018 2:00 PM - 3:00 PM CEST
Please join my meeting from your computer, tablet or smartphone. https://global.gotomeeting.com/join/454591277
You can also dial in using your phone. United States: +1 (571) 317-3117
Access Code: 454-591-277
More phone numbers Australia: +61 2 9091 7603 Austria: +43 7 2081 5337 Belgium: +32 28 93 7002 Canada: +1 (647) 497-9373 Denmark: +45 32 72 03 69 Finland: +358 923 17 0556 France: +33 170 950 590 Germany: +49 693 8098 999 Ireland: +353 15 360 756 Italy: +39 0 230 57 81 80 Netherlands: +31 207 941 375 New Zealand: +64 9 282 9510 Norway: +47 21 93 37 37 Spain: +34 932 75 1230 Sweden: +46 853 527 818 Switzerland: +41 445 1124 85 United Kingdom: +44 330 221 0097
First GoToMeeting? Let's do a quick system check: https://link.gotomeeting.com/system-check